GLIMISAVE MV 1/.3

Glimisave MV 1.3 Tablet SR is classified as an anti-diabetic medication designed for the management of type 2 diabetes mellitus in adult patients. This formulation combines multiple agents that work collectively to help regulate blood glucose levels in individuals diagnosed with diabetes. It is important to take this medication in conjunction with or just prior to meals to enhance its effectiveness. Consistency in timing is crucial, so it is advisable to take it at the same time each day. The prescribing physician will determine the most suitable dosage based on the patient’s specific needs, and adjustments may be made over time in response to blood sugar monitoring results. It is essential to continue using this medication even when feeling well or when blood sugar appears to be stable, as discontinuation without medical advice can lead to increased glucose levels, which may result in significant health complications, including potential kidney damage, vision loss, nerve issues, and amputations. This medication should complement a comprehensive treatment approach that includes a balanced diet, regular physical activity, and weight management strategies as directed by a healthcare provider. Lifestyle choices are integral to effective diabetes management. Patients should remain vigilant regarding the symptoms of hypoglycemia, such as sweating, dizziness, and shakiness, and learn appropriate responses to such events. Having quick access to a source of glucose is recommended to mitigate these risks. Consumption of alcohol is discouraged, as it may heighten the possibility of hypoglycemia. Other potential adverse reactions to this medication include altered taste sensations, gastrointestinal disturbances, headaches, swelling, blurred vision, fractures, and respiratory infections. Weight gain may also be observed in some individuals taking this medication.